https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Welcomeness for people with substance use disorders to general practice: a qualitative study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47112 Thu 23 Mar 2023 09:51:46 AEDT ]]> Absolute cardiovascular risk and GP decision making in TIA and minor stroke https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20453 Sat 24 Mar 2018 08:06:58 AEDT ]]> Comparison of a single self-assessment item with the PHQ-9 for detecting depression in general practice https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20480 Sat 24 Mar 2018 07:59:08 AEDT ]]> Antibiotic prescribing for respiratory infections: a cross-sectional analysis of the ReCEnT study exploring the habits of early-career doctors in primary care https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26889 Sat 24 Mar 2018 07:41:40 AEDT ]]> International comparison of guidelines for management of impetigo: a systematic review https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44762 Mon 24 Oct 2022 08:49:26 AEDT ]]> GP trainees' in-consultation information-seeking: associations with human, paper and electronic sources https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27838 Mon 13 Jul 2020 13:41:44 AEST ]]> Challenges and barriers associated with medication management for home nursing clients in Australia: a qualitative study combining the perspectives of community nurses, community pharmacists and GPs https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42194 Fri 19 Aug 2022 10:18:21 AEST ]]> Reducing alcohol-related harm in Australia: a simple data-based tool to assist prioritization of research and health care delivery in primary care https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36924 Fri 17 Jul 2020 08:44:43 AEST ]]> Stability of anticholinergic load in Australian community-dwelling older people: a longitudinal analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40610 n = 1768), at year one (n = 1373) and a restricted cohort (with possible or definite cognitive impairment) at year two (n = 370) had medication regimens documented by a research nurse during a home visit. Anticholinergic medicines were categorized as levels 1-3 (low-high potency) and summed for each participant as a measure of their ACL. RESULTS: Most participants had no change in ACL over time, but there was some turnover in the anticholinergic medications used. The mean change in ACL was 0.012 ± 0.99 from baseline to 12 months and −0.04 ± 1.3 from baseline to 24 months. Cardiovascular drugs were the most commonly used level 1 anticholinergics, followed by antidepressants and opioids. Antidepressants and urologicals were the most commonly used level 3 anticholinergics. The rate of anticholinergic deprescribing was equivalent to the rate of anticholinergic initiation, and commonly involved the level 1 drugs warfarin, furosemide and temazepam, and the level 3 drugs amitriptyline and oxybutynin. People with dementia had a higher ACL at baseline and year one compared with other participants. CONCLUSION: ACL of community-dwelling older people was very stable over time. This may represent lost opportunities for deprescribing as well as potentially inappropriate prescribing, particularly in those with cognitive impairment.]]> Fri 15 Jul 2022 11:49:13 AEST ]]>